Genomic evolution and resistance during pirtobrutinib therapy in covalent btk-inhibitor (cBTKi) pre-treated chronic lymphocytic leukemia patients: Updated analysis from the BRUIN study Meeting Abstract


Authors: Brown, J. R.; Desikan, S. P.; Nguyen, B.; Won, H.; Tantawy, S. I.; McNeely, S.; Marella, N.; Ebata, K.; Woyach, J. A.; Patel, K.; Tam, C. S.; Eyre, T. A.; Cheah, C. Y.; Shah, N. N.; Ghia, P.; Jurczak, W.; Balbas, M.; Nair, B.; Abada, P.; Wang, C. X.; Wang, Y.; Roeker, L. E.; Gandhi, V.; Wierda, W. G.
Abstract Title: Genomic evolution and resistance during pirtobrutinib therapy in covalent btk-inhibitor (cBTKi) pre-treated chronic lymphocytic leukemia patients: Updated analysis from the BRUIN study
Meeting Title: 65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 142
Issue: Suppl. 1
Meeting Dates: 2023 Dec 9-12
Meeting Location: San Deigo, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2023-11-01
Start Page: 326
Language: English
ACCESSION: WOS:001159306701083
DOI: 10.1182/blood-2023-180143
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lindsey Elizabeth Roeker
    143 Roeker